Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction to "Cell-Penetrating and Enzyme-Responsive Peptides for Targeted Cancer Therapy: Role of Arginine Residue Length on Cell Penetration and In Vivo Systemic Toxicity".

ACS applied materials & interfaces·2026

Same author

Non-invasive tracking of rAAV-mediated gene expression in the liver through a genetically encoded MRI reporter gene.

Molecular therapy : the journal of the American Society of Gene Therapy·2025

Same author

Desensitized to Trauma: The Jackson Water Crisis, Environmental Injustice, and Implications for Public Health Social Work.

Social work in public health·2025

Same author

Glucose stimulated CEST MRI pHe mapping for improved differentiation of tumors with altered hypoxia inducible factor 1alpha expression.

Scientific reports·2025

Same author

Large scale analysis of the SARS-CoV-2 main protease reveals marginal presence of nirmatrelvir-resistant SARS-CoV-2 Omicron mutants in Ontario, Canada, December 2021-September 2023.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2024

Same author

Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on Ultrasound.

Cancers·2024

Search research articles

Related Experiment Video

Updated: May 29, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis and diabetes in Guyana.

Bibi Alladin¹, Steve Mack, Aruna Singh

¹Faculty of Health Sciences, University of Guyana, Georgetown, Guyana.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases

|September 13, 2011

Summary

Diabetes and tuberculosis (TB) are common in Guyanese patients. Routine screening for both conditions is recommended for better patient management and outcomes.

Related Experiment Videos

Last Updated: May 29, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of ¹⁸FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

Public Health
Infectious Diseases
Endocrinology

Background:

Tuberculosis (TB) and diabetes mellitus are significant global health concerns.
The co-occurrence of TB and diabetes can complicate diagnosis and treatment.
Understanding the prevalence of diabetes among TB patients in specific regions is crucial for targeted interventions.

Purpose of the Study:

To determine the prevalence of diabetes mellitus in tuberculosis patients in Guyana.
To identify risk factors and clinical characteristics associated with diabetes in TB patients.

Main Methods:

A cross-sectional study was conducted among 100 TB patients in three Guyanese clinics.
Data on demographics, clinical history, and risk factors were collected using a structured questionnaire.
Random blood sugar testing was performed using a glucometer.

Main Results:

Fourteen percent of TB patients were found to have diabetes mellitus.
All diabetic TB patients had pulmonary TB; none were co-infected with HIV.
Diabetic TB patients were older and more likely to have been incarcerated at TB diagnosis.

Conclusions:

Diabetes is prevalent among TB patients in Guyana.
Routine screening for diabetes in TB patients and vice versa is recommended.
Collaboration between TB programs and diabetes clinics is essential for optimal management.